Modeling adaptive therapy in non-muscle invasive bladder cancer
M. C. Ferrall-Fairbanks, G. J. Kimmel, M. Black, R. Bravo, O. Deac, P. Martinez, M. Myers, F. Nazari, A. Osojnik, H. Subramanian, Y. Viossat, F. Whiting, R. Li, K. M. Mann, P. M. Altrock
This study models adaptive therapy for non-muscle invasive bladder cancer to control tumor size and reduce recurrence by analyzing mutational heterogeneity and cytokine profiles.
bioRxiv · Nov 7, 2019 · PreprintCancer Biology